je.st
news
Tag: progression
FDA Approves Mercks KEYTRUDA (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy
2016-08-08 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab), the companys anti-PD-1 (programmed death receptor-1) therapy, at a fixed dose of 200 mg every three weeks, for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orInvestor:Teri Loxam, 908-740-1898orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
FDA Approves Mercks KEYTRUDA (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy
2016-08-06 01:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab), the companys anti-PD-1 (programmed death receptor-1) therapy, at a fixed dose of 200 mg every three weeks, for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orInvestor:Teri Loxam, 908-740-1898orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
'Significant progression' as Del Monte Foods converts to non-BPA packaging
2016-03-31 08:56:04| Food - Topix.net
Hot on the heels of Campbell Soup Company's announcement that it is switching to BPA-free lined cans by 2017, Del Monte Foods, has revealed this week it is converting to non-BPA linings. Starting with the company's fresh pack production in 2016, which runs from May to October, all Del Monte fruit and tomato products, and nearly 100% of vegetable products found under the Del Monte brand will convert to non-BPA linings.
Tags: del
significant
packaging
foods
SAFETI OFFSHORE: Modelling Progression of an Offshore Hydrocarbon Release Accident
2015-11-16 01:00:00| Offshore Technology
The calculation of risks associated with hydrocarbon loss of containment incidents is a problem, which has been analyzed using models of varying complexity.
Tags: release
accident
progression
offshore
Modelling of the Progression of an Offshore Hydrocarbon Release Accident
2015-11-09 11:56:00| Hydrocarbons Technology
This paper considers the range of parameters which may have to be varied in order to carry out an analysis which accounts for the very large number of combinations and undertakes a detailed consequence analysis for each.
Tags: release
accident
progression
offshore